Radioisotopes in management of metastatic prostate cancer

INTRODUCTION: Metastatic prostate cancer continues to be a leading cause of morbidity and mortality in men with prostate cancer. Over the last decade, the treatment landscape for patients with castrate-resistant disease has drastically changed, with several novel agents demonstrating an improvement...

Descripción completa

Detalles Bibliográficos
Autores principales: Raval, Amar, Dan, Tu D., Williams, Noelle L., Pridjian, Andrew, Den, Robert B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054657/
https://www.ncbi.nlm.nih.gov/pubmed/27843209
http://dx.doi.org/10.4103/0970-1591.189708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054657/
https://www.ncbi.nlm.nih.gov/pubmed/27843209
http://dx.doi.org/10.4103/0970-1591.189708

Ejemplares similares